By Matthew Perlman ( May 14, 2015, 4:49 PM EDT) -- Clinical stage biotech firm Five Prime Therapeutics Inc. said it may raise up $200 million with future stock offerings, filing a shelf registration with the U.S. Securities and Exchange Commission on Wednesday, as another life sciences company taps the public markets this week....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.